Current Pharmacogenomics and Personalized Medicine

Author(s): Rosa Finelli, Antonietta V. Pascale, Paola Marotta, Anna Guida and Michele Ciccarelli*

DOI: 10.2174/1875692115666170508152128

DownloadDownload PDF Flyer Cite As
Tackling Cardiovascular Risk: New Evidence from Personalized Medicine

Page: [60 - 66] Pages: 7

  • * (Excluding Mailing and Handling)

Abstract

Background: The definition of the individual's molecular profile will promote a specific and tailored therapeutic approach for each patient. This method has found application in specific drug decision-making in the oncology field, but not for cardiovascular pathologies.

Objective: In this review, we describe some relevant molecular features of the cardiovascular disease in the context of personalized medicine, discussing how a multidisciplinary approach can favor its translation into daily patient management as a component of integrated care.

Conclusion: Prevention of the Cardiovascular disease still lacks efficient models for personalized medicine, but the definition of the individual Metabolomics may represent a promising approach for filling this gap.

Keywords: Cardiovascular diseases, genomics, metabolomics, innovation and communication technology, personalized medicine.

Graphical Abstract